Bicalutamide Tablet
Product Images NDC 63629-8308

4 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bicalutamide (NDC 63629-8308). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig_1 (Bicalutamide Fig 1)

Fig_1 (Bicalutamide Fig 1)
A survival curve chart comparing the proportion surviving over days to death for two treatments: Bicalutamide plus LHRH-A and Flutamide plus LHRH-A. The x-axis represents days to death up to 1825 days, and the y-axis shows the proportion surviving from 0.0 to 1.0. Two lines illustrate the survival trends for each treatment group.*
FDA Label Image

Fig_2 (Bicalutamide Fig 2)

Fig_2 (Bicalutamide Fig 2)
A survival curve chart depicting 'proportion not progressing' on the vertical axis over 'days to progression' on the horizontal axis. It compares two treatments: Bicalutamide plus LHRH-A (solid line) and Flutamide plus LHRH-A (dashed line) over a period up to approximately 1825 days.*
FDA Label Image

Chem (Bicalutamide Str)

FDA Label Image

Label Image (Lbl636298308)

Label Image (Lbl636298308)
Bicalutamide 50 mg tablet packaging label by Bryant Ranch Prepack. The label shows dosage strength (50 mg), package count (#30), comparison to Casodex 50 mg tablet by Intas Pharmaceuticals Limited, and storage instructions to keep at room temperature 20° to 25°C (68° to 77°F). Includes NDC 63629-8308 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.